Life Stem Genetics Inc (LIFS) USD0.001
Life Stem Genetics (LISF) is a healthcare company that focuses on healing with a patient's own Stem Cells. The Company intends to offer their treatments through a series of affiliate doctors, and medical clinics, with approximately 60 affiliated clinics. The Stem Cells heal various ailments and are being offered as a way to treat various illnesses ranging from orthopedic injuries, neurological disorders, such as Parkinson's, Alzheimer's, Cancer, Plastic Surgery, Age Management, Arthritis, Diabetes, Cardiology, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis and Urology. LISF's Stem Cell Therapy and techniques help to repair or re-program damaged or diseased tissues and organs.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.